The impact of Xpert® MTB/RIF in sparsely populated rural settings

International Journal of Tuberculosis and Lung Disease

Volumn 19, Issue 4, 2015, Pages 392-398

  Van Den Handel, T ^a   Hampton, K H ^b   Sanne, I ^a,c   Stevens, W ^d,e   Crous, R ^f   Van Rie, A ^b  

^a RIGHT TO CARE   (South Africa)

^b IL   (United States)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^e NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^f WESTERN CAPE DEPARTMENT OF HEALTH   (South Africa)

Author keywords

Impact; Rural; Xpert MTB RIF

Indexed keywords

ISONIAZID;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; MULTIDRUG RESISTANT TUBERCULOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RAPID TEST; RURAL AREA; RURAL POPULATION; SOUTH AFRICA; SPUTUM SMEAR; TUBERCULOSIS; TUBERCULOSIS CONTROL; CLINICAL TRIAL; COINFECTION; COMPARATIVE STUDY; HIV INFECTIONS; MICROBIOLOGY; MULTICENTER STUDY; POINT OF CARE SYSTEM; PRESCHOOL CHILD; SPUTUM; TIME TO TREATMENT; TUBERCULOSIS, MULTIDRUG-RESISTANT;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COINFECTION; FEMALE; HIV INFECTIONS; HUMANS; MALE; MICROSCOPY; POINT-OF-CARE SYSTEMS; PROSPECTIVE STUDIES; RURAL POPULATION; SOUTH AFRICA; SPUTUM; TIME-TO-TREATMENT; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84925671973     PISSN: 10273719     EISSN: 18157920     Source Type: Journal    
DOI: 10.5588/ijtld.14.0653     Document Type: Article

References (19)

1. Storla D G, Yimer S, Bjune G A. A systematic review of delay in the diagnosis and treatment of tuberculosis. BMC Public Health 2008; 8: 15.
2. Weyer K, Mirzayev F, Migliori G B, et al. Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF. Eur Respir J 2013; 42: 252-271.
3. Boehme C C, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl JMed 2010; 363: 1005-1015.
4. Steingart K R, Schiller I, Horne D J, Pai M, Boehme C C, Dendukuri N. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev 2014; 1: CD009593.
5. Van Rie A, Page-Shipp L, Scott L, Sanne I, Stevens W. Xpert® MTB/RIF for point-of-care diagnosis of TB in high-HIV burden, resource-limited countries: hype or hope? Expert Rev Mol Diagn 2010; 10: 937-946.
6. Helb D, Jones M, Story E, et al. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol 2010; 48: 229-237.
7. Raizada N, Sachdeva K S, Sreenivas A, et al. Feasibility of decentralised deployment of Xpert MTB/RIF test at lower level of health system in India. PLOS ONE 2014; 9: e89301.
8. Meyer-Rath G, Schnippel K, Long L, et al. The impact and cost of scaling up GeneXpert MTB/RIF in South Africa. PLOS ONE 2012; 7: e36966.
9. Theron G, Zijenah L, Chanda D, et al. Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary care settings in Africa: a multicentre, randomised, controlled trial. Lancet 2014; 383: 424-435.
10. Boehme C C, Nicol M P, Nabeta P, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 2011; 377: 1495-1505.
11. Hanrahan C F, Selibas K, Deery C B, et al. Time to treatment and patient outcomes among TB suspects screened by a single point-of-care xpert MTB/RIF at a primary care clinic in Johannesburg, South Africa. PLOS ONE 2013; 8: e65421.
12. Regional Development profile, Central Karoo District. Cape Town, South Africa: Western Cape Government, Provincial Treasury, 2012.
13. Statistics South Africa. Mortality and causes of death in South Africa, 2010: findings from death notification. Pretoria, South Africa: Statistics South Africa, 2013.
14. South African National Department of Health. National tuberculosis guidelines. Pretoria, South Africa: National Department of Health, 2009.
15. World Health Organization. Definitions and reporting framework for tuberculosis: 2013 revision. Geneva, Switzerland: WHO, 2013.
16. World Health Organization. Global tuberculosis report, 2013. WHO/HTM/TB/2013.11. Geneva, Switzerland: WHO, 2013.
17. st Conference on Retroviruses and Opportunistic Infections (CROI 2014), 3-6 March 2014. [Oral Abstract 95].
18. Botha E, den Boon S, Lawrence K A, et al. From suspect to patient: tuberculosis diagnosis and treatment initiation in health facilities in South Africa. Int J Tuberc Lung Dis 2008; 12: 936-941.
19. de Kantor I N, Kim S, Frieden T R, et al. Laboratory services in tuberculosis control Part 2: Microscopy. Geneva, Switzerland: WHO, 1998.